We are live on ! Find out more
LMR Partners

LMR Partners Portfolio holdings

AUM $32.6B Turnover 45.82%
1-Year Est. Return 45.61%
 

LMR Partners is a British multi-strategy investment firm named after its three founders, Ben Levine, Andrew Manuel and Stefan Renold, whose surname initials spell LMR. All three had been traders at UBS and Goldman Sachs, and Paloma Partners provided seed money before the firm began trading in 2010. Manuel left in 2015 and launched Ixworth Capital, his own global macro hedge fund. The firm focuses on global macro and event-driven strategies, mixing computer-model trading with trades chosen by its portfolio managers.

This Fund
S&P 500
This Quarter Est. Return
+4.46%
1 Year Est. Return
+45.61%
3 Year Est. Return
+238.3%
5 Year Est. Return
+283.63%
10 Year Est. Return
+733.38%
AUM
$32.6B
AUM Growth
+$5.8B
Cap. Flow
-$2.24B
Cap. Flow %
-6.88%
Top 10 Hldgs %
23.21%
Holding
1,999
New
513
Increased
354
Reduced
302
Closed
403
Avg Time Held Equity + Options
0.7 years
Top 10 Avg Time Held Equity + Options
0.2 years
Top 20 Avg Time Held Equity + Options
0.4 years
Avg Time Held Equity only
0.7 years
Top 10 Avg Time Held Equity only
0.5 years
Top 20 Avg Time Held Equity only
0.6 years

Top Buys

Rank Stock Value
1
LNTH icon
Lantheus
LNTH
+$215M
2
NVS icon
Novartis
NVS
+$116M
3
LITE icon
Lumentum
LITE
+$91.8M
4
MDT icon
Medtronic
MDT
+$90.8M
5
SHOP icon
Shopify
SHOP
+$88.5M

Sector Composition

Rank Sector Weight
1 Miscellaneous 74.57%
2 Technology 7.25%
3 Healthcare 5.19%
4 Communication Services 3.16%
5 Financials 2.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
SCHW icon
1401
Charles Schwab
SCHW
$160B
$134K ﹤0.01%
1,369
-4,496
-77% -$473K
2026 Q2
1 quarter
EQIX icon
1402
Equinix
EQIX
$103B
$130K ﹤0.01%
129
-1,726
-93% -$1.79M
2026 Q2
1 quarter
DMIIR icon
1403
Drugs Made In America Acquisition II Corp Right
DMIIR
$128K ﹤0.01%
+2,000,000
New +$156K
2026 Q3
0 quarters
SVAQW icon
1404
Silicon Valley Acquisition Corp Warrants
SVAQW
$3.44M
$125K ﹤0.01%
300,000
– –
2026 Q2
1 quarter
SMCI icon
1405
Super Micro Computer
SMCI
$16.1B
$123K ﹤0.01%
3,002
-194,621
-98% -$6.62M
2026 Q1
2 quarters
OKLO icon
1406
Oklo
OKLO
$4.26B
$123K ﹤0.01%
3,320
-11,819
-78% -$499K
2026 Q1
2 quarters
ABUS icon
1407
CALL
Arbutus Biopharma
ABUS
$630M
$120K ﹤0.01%
+25,000
New +$120K
2026 Q3
0 quarters
XNDU icon
1408
Xanadu Quantum Technologies Class B
XNDU
$602M
$114K ﹤0.01%
+25,000
New +$243K
2026 Q3
0 quarters
RAINW icon
1409
Rain Enhancement Technologies Warrants
RAINW
$500K
$114K ﹤0.01%
611,776
– –
2025 Q1
6 quarters
TMTSW icon
1410
Spartacus Acquisition Corp II Warrants
TMTSW
$113K ﹤0.01%
+283,332
New +$136K
2026 Q3
0 quarters
JENA.RT icon
1411
Jena Acquisition Corp II Rights
JENA.RT
$113K ﹤0.01%
+500,000
New +$100K
2026 Q3
0 quarters
BDCIW icon
1412
BTC Development Warrant
BDCIW
$2.02M
$112K ﹤0.01%
281,250
– –
2025 Q4
3 quarters
XLABW icon
1413
Exascale Labs Holdings Warrant
XLABW
$112K ﹤0.01%
+702,932
New +$210K
2026 Q3
0 quarters
PNAQ.U
1414
Pinnacle Acquisition Corp Units
PNAQ.U
$112K ﹤0.01%
+11,200
New +$112K
2026 Q3
0 quarters
FULC icon
1415
Fulcrum Therapeutics
FULC
$284M
$111K ﹤0.01%
30,000
– –
2025 Q2
5 quarters
MLAAW icon
1416
Mountain Lake Acquisition Corp II Warrants
MLAAW
$109K ﹤0.01%
625,000
– –
2026 Q2
1 quarter
AZO icon
1417
AutoZone
AZO
$53.3B
$108K ﹤0.01%
+38
New +$114K
2026 Q3
0 quarters
ACGCW icon
1418
ACP Holdings Acquisition Corp Warrants
ACGCW
$108K ﹤0.01%
+250,000
New +$89.6K
2026 Q3
0 quarters
RAC.WS icon
1419
Rithm Acquisition Corp Warrants
RAC.WS
$107K ﹤0.01%
266,666
– –
2025 Q3
4 quarters
JD icon
1420
JD.com
JD
$33.7B
$107K ﹤0.01%
+4,009
New +$116K
2026 Q3
0 quarters
SVCCW icon
1421
Stellar V Capital Corp Warrant
SVCCW
$1.17M
$106K ﹤0.01%
425,000
– –
2025 Q1
6 quarters
CNCKW icon
1422
Coincheck Group Warrant expiring 12/10/2029
CNCKW
$632K
$104K ﹤0.01%
521,260
– –
2025 Q1
6 quarters
DJT icon
1423
Trump Media & Technology Group
DJT
$1.13B
$104K ﹤0.01%
+11,482
New +$105K
2026 Q3
0 quarters
BBAI.WS icon
1424
BigBear.ai Holdings Warrant
BBAI.WS
$4.54M
$103K ﹤0.01%
1,290,816
– –
2024 Q4
7 quarters
MPLT icon
1425
MapLight Therapeutics
MPLT
$370M
$102K ﹤0.01%
10,000
– –
2025 Q4
3 quarters

Similar funds

LMR Partners's Q3 2026 Portfolio in Review

As of Q3 2026, LMR Partners held 1,999 positions worth $32.6B, up 22% from $26.8B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

LMR Partners withdrew a net $2.24B in Q3 2026, closing 403 positions and reducing 302 holdings. Its most notable exit was Chart Industries, an estimated $109M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 75% of assets, up from 71% a quarter earlier, followed by Technology and Healthcare.

Against the trend, LMR Partners opened a new position in Lantheus worth $210M.

  • LMR Partners's largest Q3 2026 buy was Lantheus: 2,108,000 shares worth $210M.
  • LMR Partners added most to Novartis in Q3 2026, an estimated $116M increase.
  • LMR Partners's biggest Q3 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $632M.
  • LMR Partners fully exited Chart Industries in Q3 2026, selling an estimated $109M.
  • LMR Partners's ten largest holdings make up 23% of its $32.6B portfolio in Q3 2026.
  • LMR Partners opened 513 new positions and closed 403 in Q3 2026.
  • LMR Partners's portfolio value rose 22% quarter-over-quarter to $32.6B.

Based on LMR Partners's 13F filing for Q3 2026, filed 16 Nov 2026.